欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Dyrupeg Human pegfilgrastim pegfilgrastim EMEA/H/C/006407 CuraTeQ Biologics s.r.o 2025/03/28 Authorised
Tivdak Human tisotumab vedotin tisotumab vedotin EMEA/H/C/005363 Genmab A/S 2025/03/28 Authorised
Capvaxive Human pneumococcal polysaccharide conjugate vaccine (21-valent) pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein EMEA/H/C/006267 Merck Sharp & Dohme B.V.  2025/03/24 Authorised
Rytelo Human imetelstat imetelstat EMEA/H/C/006105 Geron Netherlands B.V. 2025/03/07 Authorised
Wainzua Human eplontersen eplontersen sodium EMEA/H/C/006295 AstraZeneca AB  2025/03/06 Authorised
Tuzulby Human methylphenidate hydrochloride methylphenidate hydrochloride EMEA/H/C/005975 Neuraxpharm Pharmaceuticals S.L. 2025/02/28 Authorised
Vimkunya Human Chikungunya vaccine (recombinant, adsorbed) Chikungunya virus (CHIKV) virus-like particle (VLP) proteins (capsid protein (C) and envelope proteins E1 and E2) derived from CHIKV Senegal strain 37997 produced in human embryonic kidney cells by recombinant DNA technology, adsorbed on aluminium hydroxide, hydrated EMEA/H/C/005470 Bavarian Nordic A/S 2025/02/28 Authorised
Paxneury Human guanfacine guanfacine hydrochloride EMEA/H/C/006312 Neuraxpharm Pharmaceuticals S.L. 2025/02/26 Authorised
Avtozma Human tocilizumab tocilizumab EMEA/H/C/006196 Celltrion Healthcare Hungary Kft. 2025/02/14 Authorised
Stoboclo Human denosumab denosumab EMEA/H/C/006156 Celltrion Healthcare Hungary Kft. 2025/02/14 Authorised
Yesintek Human ustekinumab ustekinumab EMEA/H/C/006444 Biosimilar Collaborations Ireland Limited 2025/02/14 Authorised
Osenvelt Human denosumab denosumab EMEA/H/C/006157 Celltrion Healthcare Hungary Kft. 2025/02/14 Authorised
Kostaive Human zapomeran COVID-19 sa-mRNA Vaccine EMEA/H/C/006207 Seqirus Netherlands B.V. 2025/02/12 Authorised
Nemluvio Human nemolizumab nemolizumab EMEA/H/C/006149 Galderma International 2025/02/12 Authorised
Welireg Human belzutifan belzutifan EMEA/H/C/005636 Merck Sharp & Dohme B.V. 2025/02/12 Authorised
Obodence Human denosumab denosumab EMEA/H/C/006424 Samsung Bioepis NL B.V. 2025/02/12 Authorised
Eydenzelt Human aflibercept aflibercept EMEA/H/C/005899 Celltrion Healthcare Hungary Kft. 2025/02/12 Authorised
Zefylti Human filgrastim filgrastim EMEA/H/C/006400 CuraTeQ Biologics s.r.o 2025/02/12 Authorised
Xbryk Human denosumab denosumab EMEA/H/C/006468 Samsung Bioepis NL B.V. 2025/02/12 Authorised
Emcitate Human tiratricol tiratricol EMEA/H/C/005220 Rare Thyroid Therapeutics International AB 2025/02/12 Authorised

数据库说明:

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase